UB Paderborn / Katalog / Suche / in CDI

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS‐CoV‐2 infection

Journal of medical virology, 2021-05, Vol.93 (5), p.3152-3157

2021

Volltextzugriff (PDF)

First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine

Journal of antimicrobial chemotherapy, 2019-09, Vol.74 (9), p.2752-2758

2019

Volltextzugriff (PDF)

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Volltextzugriff (PDF)

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals

Clinical infectious diseases, 2018-05, Vol.66 (11), p.1762-1769

2018

Volltextzugriff (PDF)

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

Journal of hepatology, 2021-01, Vol.74 (1), p.37-47

2021

Volltextzugriff (PDF)

Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against Monkeypox should receive a 3-dose regimen

Infectious diseases now (Online), 2022-11, Vol.52 (8), p.459-460

2022

Volltextzugriff (PDF)

Why are people still dying of drug-susceptible TB in Paris in the 21 st century?

The international journal of tuberculosis and lung disease, 2022-02, Vol.26 (2), p.142

2022

Volltextzugriff (PDF)

Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3660-3662

2015

Volltextzugriff (PDF)

Intravesical BCG instillation as a possible cause of acute and chronic kidney injury

Infectious diseases now (Online), 2021-03, Vol.51 (2), p.209-211

2021

Volltextzugriff (PDF)

Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)

Journal of viral hepatitis, 2007-03, Vol.14 (3), p.183-188

2007

Volltextzugriff (PDF)

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

Euro surveillance : bulletin européen sur les maladies transmissibles, 2014-04, Vol.19 (14), p.1

2014

Volltextzugriff (PDF)

Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?

Clinical microbiology and infection, 2016-09, Vol.22 (9), p.757-767

2016

Volltextzugriff (PDF)

Imported filariasis in Europe: A series of 31 cases from Metropolitan France

European journal of internal medicine, 2017-01, Vol.37, p.e37-e39

2017

Volltextzugriff (PDF)

Imported malaria in pregnant women: report from a French University Centre

Infection, 2018-02, Vol.46 (1), p.119-122

2018

Volltextzugriff (PDF)

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2910-2919

2010

Volltextzugriff (PDF)

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

Journal of antimicrobial chemotherapy, 2017-11, Vol.72 (11), p.3172-3176

2017

Volltextzugriff (PDF)

P754 INCREASING RATE OF UNTREATED HCV INFECTION IN HIV–HCV COINFECTED PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S322-S322

2014

Volltextzugriff (PDF)

P0813 : All oral therapy (Sofosbuvir–Ribavirin) combination in severe HCV-mixed cryoglobulinemia vasculitis, the vascuvaldic study

Journal of hepatology, 2015-04, Vol.62, p.S640-S640

2015

Volltextzugriff (PDF)

Evaluation of a computer algorithm for promoting both annual hepatitis C screening and hepatitis B vaccination among HIV-infected individuals (ORCHESTRA programme)

International journal of STD & AIDS, 2011-10, Vol.22 (10), p.613

2011

Volltextzugriff (PDF)

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004

Euro surveillance : bulletin européen sur les maladies transmissibles, 2008-05, Vol.13 (22)

2008

Volltextzugriff (PDF)

Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France

Value in health, 2014-11, Vol.17 (7), p.A678-A679

2014

Volltextzugriff (PDF)

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

The New England journal of medicine, 2020-03, Vol.382 (13), p.1232-1243

2020

Volltextzugriff (PDF)

1158 PEG-IFNA/RIBAVIRIN/PROTEASE INHIBITOR COMBINATION IS HIGHLY EFFECTIVE IN HCV-MIXED CRYOGLOBULINEMIA VASCULITIS

Journal of hepatology, 2012-04, Vol.56, p.S458-S458

2012

Volltextzugriff (PDF)

796 FACTORS ASSOCIATED WITH SUSTAINED VIROLOGICAL RESPONSE IN HCV/HIV PATIENTS RETREATED WITH PEG-INTERFERON-a2a-360 μg/wk AND RIBAVIRIN HIGH DOSE: RESULTS OF THE ANRS-HC-20 ETOC STUDY

Journal of hepatology, 2013-04, Vol.58, p.S325-S325

2013

Volltextzugriff (PDF)

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

The New England journal of medicine, 2015-12, Vol.373 (23), p.2237-2246

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS‐CoV‐2 infection

First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against Monkeypox should receive a 3-dose regimen

Why are people still dying of drug-susceptible TB in Paris in the 21 st century?

Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy

Intravesical BCG instillation as a possible cause of acute and chronic kidney injury

Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?

Imported filariasis in Europe: A series of 31 cases from Metropolitan France

Imported malaria in pregnant women: report from a French University Centre

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

P754 INCREASING RATE OF UNTREATED HCV INFECTION IN HIV–HCV COINFECTED PATIENTS

P0813 : All oral therapy (Sofosbuvir–Ribavirin) combination in severe HCV-mixed cryoglobulinemia vasculitis, the vascuvaldic study

Evaluation of a computer algorithm for promoting both annual hepatitis C screening and hepatitis B vaccination among HIV-infected individuals (ORCHESTRA programme)

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004

Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

1158 PEG-IFNA/RIBAVIRIN/PROTEASE INHIBITOR COMBINATION IS HIGHLY EFFECTIVE IN HCV-MIXED CRYOGLOBULINEMIA VASCULITIS

796 FACTORS ASSOCIATED WITH SUSTAINED VIROLOGICAL RESPONSE IN HCV/HIV PATIENTS RETREATED WITH PEG-INTERFERON-a2a-360 μg/wk AND RIBAVIRIN HIGH DOSE: RESULTS OF THE ANRS-HC-20 ETOC STUDY

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

Suchergebnisse filtern